Rx for Drug Marketers: Tackling DTC

Nov 01, 2002

In early October, the Advertising Club of New York sponsored a luncheon titled "Rx for Drug Marketers: Tackling DTC." Representatives from pharma companies, agencies, media, and government participated in a panel discussion, with each member offering their "take" on DTC marketing. Panel members, pictured here from left to right, are Cliff Thumma, director, market analytics, Pfizer; Mark Morris, chairman, Bates North America; Bob Ziltz, national ad director, Prevention magazine; Sibyl Shalo, senior editor, Pharmaceutical Executive; Kathryn Aikin, PhD, social science analyst, division of drug, marketing, advertising, and communications, FDA; Deborah Dick-Rath, executive director, global advertising, Novartis Pharmaceuticals; Joanne Davis, president, joanne davis consulting and Advertising Club board member.

lorem ipsum